VISTA PHARMACEUTICALS LTD. Share Price

VISTA PHARMACEUTICALS LTD. Share Price

BSE: 524711
|
Pharmaceuticals
|
S Cap
₹ 6.24
+₹0.15 (2.46%)
1D
Last updated 03 Sep, 2026, 15:26 IST

VISTA PHARMACEUTICALS LTD. Share Price Today

As of 4 Sep 2026, VISTA PHARMACEUTICALS LTD. share price is ₹6.24. The stock opened at ₹6.10, compared to its previous close of ₹6.09. During today's trading session, VISTA PHARMACEUTICALS LTD. share price moved in the range of ₹6.10 to ₹6.44, with an average price of ₹6.27 for the day. Looking at its last 52-week, the stock has touched a low of ₹5.71 and a high of ₹10.75.

₹6.10
2.46% up today
₹6.44
1D LOW
1D HIGH

VISTA PHARMACEUTICALS LTD. Returns Calculator

Circuit
L
H
₹4.88
₹7.30
52-week
L
H
₹5.71
₹10.75

About VISTA PHARMACEUTICALS LTD.

VISTA PHARMACEUTICALS LTD. Share Price
ISIN
INE427C01021
Sector Market Cap
₹ 37.49 Cr

Vista Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical products. The Company offers over the counter and prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company has its United States Food and Drug Administration (USFDA) approved manufacturing facility in India and its marketing and distribution center in United States. Its products include tablet dosage forms and capsule dosage forms. The Company's tablet dosage forms in United States market include sulfamethoxazole & trimethoprim (400/80 mg) and acetaminophen (500 mg) film coated. The Company's tablet dosage forms in Non-United States market include aspirin (300, 325 & 500 mg), atenolol (50 & 100 mg), cotrimoxazole (480 mg), captopril (25 & 50 mg) and frusemide (40 mg). Its capsule dosage forms in Non-United States market include indomethacin (25 mg), piroxicam (10 & 20 mg) and nifedipine (10 mg).

VISTA PHARMACEUTICALS LTD. Financial Highlights

  • Revenue: VISTA PHARMACEUTICALS LTD. reported revenue of ₹5.72 crore in FY26 vs ₹10.51 crore in FY25. It showed a decrease of 45.58% on a yearly basis.
  • Operating Profit: VISTA PHARMACEUTICALS LTD. reported an operating loss of ₹16.15 crore in FY26 vs ₹5.29 crore in FY25. It showed a decrease of 205.29% on a year-on-year basis.
  • Net Profit: VISTA PHARMACEUTICALS LTD. reported a net loss of ₹12.06 crore in FY26 vs ₹4.65 crore in FY25. It showed a decrease of 159.35% on a yearly basis.

VISTA PHARMACEUTICALS LTD. Quarterly Result Highlights

  • VISTA PHARMACEUTICALS LTD. reported revenue of ₹0.04 crore in Jun 2026, compared with ₹0.03 crore in Mar 2026, representing an increase of 33.33% on a quarter-on-quarter (QoQ) basis.
  • VISTA PHARMACEUTICALS LTD. reported an operating loss of ₹1.33 crore in Jun 2026, compared with ₹7.77 crore in Mar 2026, representing an increase of 82.88% on a quarter-on-quarter (QoQ) basis.
  • VISTA PHARMACEUTICALS LTD. reported a loss of ₹0.99 crore in Jun 2026, compared with ₹5.86 crore in Mar 2026, reflecting an increase of 83.11% on a QoQ basis.
  • The earnings per share (EPS) of VISTA PHARMACEUTICALS LTD. stood at ₹0.79 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
21.19%
FII
0.00%
Other DII
0.00%
Retail and other
78.79%
Mutual funds
0.02%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
37.49
P/E
-3.19
P/B
1.03
ROE
-33.10%
D/E
0.27
ROCE
-32.42%
Div. Yield
0.00%
EPS(TTM)
-1.96
Turnover
0.07
EV/EBITDA
-3.34
Net Margin
0.00%
Op. Margin
0.00%
ROA
-21.35%
Quick Ratio
0.00
Curr. Ratio
1.81
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Vista Pharma. has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Vista Pharma. appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Mankind Pharma98,304.7047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

VISTA PHARMACEUTICALS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹10.07₹10.29₹1.00₹0.39
Other Income₹0.44₹0.33₹0.40₹0.17
Total Revenue₹10.52₹10.62₹1.40₹0.56
Total Expenses₹15.81₹15.54₹7.28₹3.18
Profit Before Tax-₹5.29-₹5.18-₹5.88-₹2.62
Tax-₹0.64-₹0.67-₹0.21-₹1.73
Profit After Tax-₹4.65-₹4.51-₹5.66-₹0.89
EPS - Basic-₹0.79-₹1.03-₹1.54-₹0.24
EPS - Diluted-₹0.79-₹0.75-₹0.90-₹0.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹5.29-₹5.18-₹5.88-₹2.62
Income before WC changes-₹3.56-₹3.24-₹4.05-₹1.11
Change in Assets-₹0.91-₹1.32-₹0.49-₹0.17
Change in Liabilities-₹2.09-₹0.36₹1.78₹0.29
Change in WC-₹3.00-₹1.68₹1.28₹0.12
Cash flow from Operations-₹6.98-₹4.91-₹1.71-₹0.99
Cash flow from Investing-₹0.44-₹0.79-₹1.27-₹0.01
Cash flow from Financing₹8.06₹5.59₹3.11₹0.94
Total Cash Flow₹0.64-₹0.11₹0.13-₹0.07
Cash (Start of the year)₹0.09₹0.20₹0.07₹0.14
Cash (End of the year)₹0.73₹0.09₹0.20₹0.07

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹35.38₹34.58₹32.28₹32.03
Current Assets₹24.91₹23.40₹23.75₹23.56
Total Assets₹60.29₹57.98₹56.03₹55.59
Current Liabilities₹12.37₹14.49₹14.08₹12.64
Net Current Asset₹12.54₹8.90₹9.67₹10.92
Non-Current Liabilities₹2.50₹3.02₹5.24₹7.50
Equity Capital₹45.42₹40.46₹36.71₹35.45
Total Equity & Liabilities₹60.29₹57.98₹56.03₹55.59
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
44.64
Neutral
ATR (14)
0.63
Neutral
STOCH(9,6)
29.73
Neutral
STOCH RSI (14)
60.84
Neutral
ADX(9)
18.95
Bullish
UO(9)
40.21
Neutral
ROC(12)
-0.95
Bearish
WillR(14)
-70.27
Neutral
Period
Simple value
Exponential vaue
5D
6.14
6.16
10D
6.28
6.26
20D
6.48
6.43
50D
6.85
6.76
100D
7.21
7.03
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
VISTA PHARMACEUTICALS LTD. Share Price
VISTA PHARMACEUTICALS LTD.
Pharmaceuticals
Add Stock
Add Another

VISTA PHARMACEUTICALS LTD. Share Price FAQs

VISTA PHARMACEUTICALS LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837